These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 16908054)
21. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770 [TBL] [Abstract][Full Text] [Related]
22. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
23. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
24. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL; Rogers LM; Ramakrishnan S; Downs LS Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502 [TBL] [Abstract][Full Text] [Related]
25. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
27. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Wang W; Sima N; Kong D; Luo A; Gao Q; Liao S; Li W; Han L; Wang J; Wang S; Lu Y; Wang D; Xu G; Zhou J; Meng L; Ma D Cancer Lett; 2010 May; 291(1):67-75. PubMed ID: 19903581 [TBL] [Abstract][Full Text] [Related]
28. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter. He Y; Huang L Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284 [TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki]. Niu XY; Peng ZL; Wang H Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169 [TBL] [Abstract][Full Text] [Related]
30. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. Daemen T; Pries F; Bungener L; Kraak M; Regts J; Wilschut J Gene Ther; 2000 Nov; 7(21):1859-66. PubMed ID: 11110419 [TBL] [Abstract][Full Text] [Related]
31. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644 [TBL] [Abstract][Full Text] [Related]
33. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075 [TBL] [Abstract][Full Text] [Related]
34. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746 [TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
36. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite. Chou RH; Huang H Biochem Biophys Res Commun; 2002 Apr; 293(1):298-306. PubMed ID: 12054599 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha. Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962 [TBL] [Abstract][Full Text] [Related]
38. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Rose BR; Thompson CH; Tattersall MH; Elliott PM; Dalrymple C; Cossart YE Gynecol Oncol; 1995 Feb; 56(2):239-44. PubMed ID: 7896192 [TBL] [Abstract][Full Text] [Related]
39. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Du J; Chen GG; Vlantis AC; Chan PK; Tsang RK; van Hasselt CA Cancer Lett; 2004 Mar; 205(1):81-8. PubMed ID: 15036664 [TBL] [Abstract][Full Text] [Related]
40. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]